Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Deals & Financings

VC fundings, mergers and acquisitions, and other financing events...

Suzhou Ribo Raises $29 Million for siRNA Drug Development

Alphamab Oncology Tees Up $350 Million Hong Kong IPO

Luye Pharma to Pay $205 Million to Acquire Shandong Boan Biological

Aslan Pharma Raises $12.8 Million in NASDAQ Secondary Offering

EOC Pharma Raises $71 Million in C Round for China Development of In-Licensed Oncology Drugs

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China